Follow Us For The Latest Updates

Follow Us For The Latest Updates

Serba Dinamik, MMC Corporation and Pharmaniaga calls take centre stage

Warrants over Malaysian stocks were the primary driver with RM139.4mil traded, with Serba Dinamik (SERBADK), MMC Corporation (MMCCORP) and Pharmaniaga (PHARMA) being the top 3 popular underlyings last week.
macquarie structured warrants 20200914

As the country enters a 14-day Full Movement Control Order (FMCO) on 1 June, the Malaysia warrants market saw an uptick in trading interest last week, recording a total RM175.2mil turnover which is 71.5% higher week-on-week (w-o-w). Warrants over Malaysian stocks were the primary driver with RM139.4mil traded, with Serba Dinamik (SERBADK), MMC Corporation (MMCCORP) and Pharmaniaga (PHARMA) being the top 3 popular underlyings last week.

There were several eye-catching headlines last week, led by the resumption of trading in SERBADK shares on Monday after two days of suspension on the prior week following the flagging of its external auditors over the company’s financial accounts, followed by Tan Sri Syed Mokhtar’s proposal to bring MMCCORP private via a selective capital reduction (SCR) at RM2 per share last Friday (The Edge Market, 4 Jun). The share price of SERBADK plunged more than 47.5% w-o-w to finish at RM0.765, which is its lowest level since 2017. Call warrants SERBADK-C17 and SERBADK-C25 secured the top and fourth spot on the list with 119.0mil and 86.1mil units traded. On the contrary, the share price of MMCCORP jumped approximately 44.4% w-o-w to close at RM1.69. Since the stock was trading at limit up (RM1.69) throughout the day last Friday, bullish investors switched their focus to MMCCORP call warrants, out of which, MMCCORP-C23 was the most popular call warrant with 89.0mil units traded, followed by MMCCORP-C24 and MCCCORP-C25. 

Besides, more than 67.4mil units of PHARMA-CC exchanged hands last week as PHARMA shares saw a rollercoaster week. On Monday, the share price of the pharmaceutical group limits up (+29.8%) but subsequently reversed its course to finish flat for the week despite news that PHARMA has received a request to supply seven million doses of Sinovac Covid-19 vaccine to government-linked companies and the state government on Tuesday (The Edge Markets, 1 Jun). Lastly, Hang Seng Index (HSI) warrants continued to dominate the index warrants space with investors being more downside biased, which resulted in put warrant HSI-HGN being the second most popular warrant in Malaysia last week.

Top warrants by volume traded:

Warrant nameVolume (mil.)IssuerExercise level/priceExpiry date
SERBADK-C17119.0Maybank1.4830 Nov 2021
HSI-HGN107.1Macquarie28,00029 Jun 2021
MMCCORP-C2389.0RHB1.0027 Aug 2021
SERBADK-C2586.1AmInvestment1.7520 Jan 2022
PHARMA-CC67.4RHB5.8828 Jul 2021

If you have any questions or need further assistance, please do not hesitate to contact us via our hotline at 03-2059 8840 or email us at [email protected]

To view the full list of structured warrants available on Bursa Malaysia, kindly visit

Provided for Malaysian residents information only. This commentary has not been reviewed by the Securities Commission Malaysia. It is not an offer or recommendation to trade and is not research material. Past performance is not indicative of future performance. You should make your own assessment and seek professional advice. The Warrants will not be offered to any US persons.


Share on facebook
Share on twitter
Share on linkedin
Share on telegram

More Posts

Serba Dinamik Holdings Bhd – 25th Jun 21

The on-going saga that resulted in diminishing of investors’ confidence is expected to see both institutional and retail investors continue to keep their hands off for the time being. Hence, we reiterate our stance to advise investors to steer clear of further position, pending for further clarity from the special independent audit review. Under the prevailing market events, on-going coverage is now impracticable to comply with applicable regulations and hence, we have decided to suspend our coverage on Serba Dinamik. Given the prolonged uncertainties, we have now lowered our valuations metrics and our fair value is RM0.57 (down from RM1.30).

market pulse

Dour trend may persist

The unabated Covid-19 spread in the country which may lead to further pressure on the economy, coupled with the concerns over the revised nation’s growth projection by World Bank have sent the FBM KLCI lower. Following a heavy selldown, we might anticipate bargain hunting activities to emerge on the local bourse. On a side note, the government has approved the licence and incentives for Risen Energy Co Ltd to manufacture solar cells and solar modules in Malaysia amounting to RM42.2bn, which would make Malaysia an integrated production hub for solar products.

Chin Well Holdings Bhd – 24th Jun 21

We are ceasing coverage on Chin Well Holdings Bhd due to reallocation of internal resources and the lack of retail and institutional interest. We expect trading activities to also taper in tandem with the commodities price which appears to have peaked as the Chinese government has step in to tame the surging prices by releasing industrial metals from its national reserves this month as it is difficult for manufacturers to transfer these costs to the end-users. Our last recommendation on Chin Well was HOLD with a fair value at RM1.29. The fair value is derived from ascribing a target PER of 11.0x to its FY22f EPS of 11.7 sen.

market pulse

Hovering near support

The FBM KLCI failed to extend its gains amid pervasive negative sentiment and weak buying interest, bucking the regional uptrend. With the World Bank cutting Malaysia’s 2021 GDP growth projection amid slower-than-expected economic recovery, the sideways trade is likely to persist without a fresh catalyst under the current economic and public health crisis. Investors may also look at the US’s 1Q21 GDP growth rate, while Bank of England’s interest rate decision, which will be releasing tonight. Commodities wise, the oil price has risen above the USD 75 per barrel level.